From the SightMD, Babylon, New York (Nattis, Rosenberg); NYIT-COM, Old Westbury, New York (Rasool).

Corresponding author: Alanna S. Nattis, DO, FAAO, SightMD, 500 W Main Street, Suite 210, Babylon, NY 11702. Email: [email protected].

Supported by a research grant from Ocular Therapeutix, Inc.

Presented in part at the ASCRS Annual Meeting, Las Vegas, Nevada, July 2021.

Disclosures: The authors have received financial and/or equipment research support from Alcon Laboratories, Inc. (A.S.N., E.D.R.), Glaukos Corp. (A.S.N., E.D.R.), Ocular Therapeutix, Inc. (A.S.N., E.D.R.), Novartis Corp. (A.S.N.), Sight Sciences (A.S.N., E.D.R.), Tarsus (A.S.N., E.D.R.), Zeiss (E.D.R.), Eyevance (E.D.R.), Beaver-Visitec International (E.D.R.), Omeros Corp. (E.D.R.), and New World Medical, Inc. (E.D.R.) in the past 3 years.

First author:Alanna S. Nattis, DO, FAAOSightMD, Babylon, New York